Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2017

30.06.2017 | Original Article

Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012

verfasst von: Felipe Bellolio Roth, Javier Gómez, Jaime Cerda

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Aim

To determine the number of annual hospital discharges for inflammatory bowel diseases in Chile. The hypothesis is that there is a significant increase in the hospital discharges due to this disease from 2001 to 2012.

Materials and Methods

This is a descriptive study. Data were obtained from the Web site of the Department of Health Statistics. All hospital discharges from 2001 to 2012 were included. The following variables were analyzed: length of stay, hospital mortality, and eventual surgical procedure. Data are presented as descriptive statistics. The B-coefficient was calculated to establish the significance of the annual trend.

Results

There were 13,001 hospital discharges with the diagnosis of ulcerative colitis or Crohn’s disease, corresponding to 0.067% of all hospital discharges in the whole period. Within these discharges, 31.2% were Crohn’s disease and 68.8% were ulcerative colitis. At least one surgical procedure was performed in 12.9% of the hospitalizations. There was a significant increase in the annual rate of hospital discharges from 5.25 in 2001 to 8.64 per 100 thousand inhabitants in 2012. This increase was from 1.68 to 3.11 in Crohn’s disease and from 3.58 to 5.53 in ulcerative colitis. However, a decrease was observed in length of stay, need of surgical treatment and in-hospital mortality.

Conclusion

From 2001 until 2012, there has been a significant increase in hospital discharges for inflammatory bowel diseases in Chile, associated with a decrease in length of stay, need of surgery and in-hospital mortality.
Literatur
2.
Zurück zum Zitat Nguyen G, Tuskey A, Dassopoulos T, et al. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007;13:1529–1535.CrossRefPubMed Nguyen G, Tuskey A, Dassopoulos T, et al. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm Bowel Dis. 2007;13:1529–1535.CrossRefPubMed
4.
Zurück zum Zitat Jakubowski A, Zagorowicz E, Kraszewska E, et al. Rising hospitalization rates for inflammatory bowel disease in Poland. Pol Arch Med Wewn. 2014;124:180–190.PubMed Jakubowski A, Zagorowicz E, Kraszewska E, et al. Rising hospitalization rates for inflammatory bowel disease in Poland. Pol Arch Med Wewn. 2014;124:180–190.PubMed
5.
Zurück zum Zitat Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274–1282.CrossRefPubMed Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274–1282.CrossRefPubMed
6.
Zurück zum Zitat Smyth C, Bacheer S, Rathore O, et al. Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996–2001. Ir J Med Sci. 2005;174:28–32.CrossRefPubMed Smyth C, Bacheer S, Rathore O, et al. Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996–2001. Ir J Med Sci. 2005;174:28–32.CrossRefPubMed
7.
Zurück zum Zitat Benchimol E, Mack D, Guttman A, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol. 2015;110:553–563.CrossRefPubMed Benchimol E, Mack D, Guttman A, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol. 2015;110:553–563.CrossRefPubMed
8.
Zurück zum Zitat Bewtra M, Su C, Lewis J. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2007;5:597–601.CrossRefPubMed Bewtra M, Su C, Lewis J. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2007;5:597–601.CrossRefPubMed
9.
Zurück zum Zitat Figueroa C, Quera R, Valenzuela J, et al. Inflammatory bowel disease: experience of two Chilean centers. Rev Med Chile. 2005;133:1295–1304. Figueroa C, Quera R, Valenzuela J, et al. Inflammatory bowel disease: experience of two Chilean centers. Rev Med Chile. 2005;133:1295–1304.
10.
Zurück zum Zitat Simian D, Fluxa D, Flores L, et al. inflammatory bowel disease: a descriptive study of 716 local Chilean patients. World J Gastroenterol. 2016;22:5267–5275.CrossRefPubMedPubMedCentral Simian D, Fluxa D, Flores L, et al. inflammatory bowel disease: a descriptive study of 716 local Chilean patients. World J Gastroenterol. 2016;22:5267–5275.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Rautava S, Ruuskanen O, Ouwehand A, et al. The hygiene hypothesis of atopic disease an extended version. J Pediatr Gastroenterol Nutr. 2004;38:378–388.CrossRefPubMed Rautava S, Ruuskanen O, Ouwehand A, et al. The hygiene hypothesis of atopic disease an extended version. J Pediatr Gastroenterol Nutr. 2004;38:378–388.CrossRefPubMed
12.
Zurück zum Zitat Bloomfield S, Rook G, Scott E, et al. Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public Health. 2016;136:213–224.CrossRefPubMedPubMedCentral Bloomfield S, Rook G, Scott E, et al. Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public Health. 2016;136:213–224.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Luque C, Cisternas F, Araya M. Cambios del patrón de enfermedad en la postransición epidemiológica en salud en Chile, 1950–2003. Rev Med Chile. 2006;134:703–712.CrossRefPubMed Luque C, Cisternas F, Araya M. Cambios del patrón de enfermedad en la postransición epidemiológica en salud en Chile, 1950–2003. Rev Med Chile. 2006;134:703–712.CrossRefPubMed
14.
Zurück zum Zitat Raval M, Schnitzler M, O’Connor B, et al. Improved outcome due to increased experience and individualized management of leaks after ileal pouch-anal anastomosis. Ann Surg. 2007;246:763–770.CrossRefPubMed Raval M, Schnitzler M, O’Connor B, et al. Improved outcome due to increased experience and individualized management of leaks after ileal pouch-anal anastomosis. Ann Surg. 2007;246:763–770.CrossRefPubMed
15.
Zurück zum Zitat Fazio V, Tekkis P, Remzi F, et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg. 2003;238:605–617.PubMedPubMedCentral Fazio V, Tekkis P, Remzi F, et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg. 2003;238:605–617.PubMedPubMedCentral
16.
Zurück zum Zitat Sakatani A, Fujiya M, Ito T, et al. Infliximab extends the duration until the first surgery in patients with Crohn’s disease. Biomed Res Int 2013;2013 Article ID 879491. Sakatani A, Fujiya M, Ito T, et al. Infliximab extends the duration until the first surgery in patients with Crohn’s disease. Biomed Res Int 2013;2013 Article ID 879491.
17.
Zurück zum Zitat Sokol H, Seksik P, Cosnes J. Complications and surgery in the inflammatory bowel diseases biological era. Curr Opin Gastroenterol. 2014;30:378–384.CrossRefPubMed Sokol H, Seksik P, Cosnes J. Complications and surgery in the inflammatory bowel diseases biological era. Curr Opin Gastroenterol. 2014;30:378–384.CrossRefPubMed
18.
Zurück zum Zitat Devaraj B, Kaiser A. Surgical management of ulcerative colitis in the era of biologicals. Inflamm Bowel Dis. 2015;21:208–220.CrossRefPubMed Devaraj B, Kaiser A. Surgical management of ulcerative colitis in the era of biologicals. Inflamm Bowel Dis. 2015;21:208–220.CrossRefPubMed
Metadaten
Titel
Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012
verfasst von
Felipe Bellolio Roth
Javier Gómez
Jaime Cerda
Publikationsdatum
30.06.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4660-5

Weitere Artikel der Ausgabe 9/2017

Digestive Diseases and Sciences 9/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.